Trial intelligence / Profile preview

Remimazolam vs Balanced Anesthesia in EC-IC Bypass Surgery

NCT05557253Unknown

Sponsor
Seoul National University Hospital
Start
Oct 2022
Primary completion
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of remimazolam in intraoperative hypotension (IOH) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Intraoperative hypotension. Status: unknown.

02

Drugs

remimazolam
03

Conditions

intraoperative hypotension (IOH)

Beyond the preview

Go deeper on NCT05557253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05557253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call